What we found on the web about Byetta
Exenatide - Wikipedia, the free encyclopedia
Exenatide (INN, marketed as Byetta) is one of a new class of medications (incretin mimetics) approved (Apr 2005) for the treatment of diabetes mellitus type 2.
Gila monster - Wikipedia, the free encyclopedia
^"Exenatide (Byetta) as a novel treatment option for type 2 diabetes mellitus". Baylor University Medical Center Proceedings 19 (3): 281–4. PMID 17252050.
Byetta SubQ : Uses, Side Effects, Interactions, Pictures, Warnings ...
Find patient medical information for Byetta SubQ on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings
Diabetes Monitor - press release: New Storage Instructions Approved ...
New Storage Instructions Approved For BYETTA® Refrigeration No Longer Required After First Use S AN DIEGO, CA and INDIANAPOLIS, IN, February 20, 2007 - Amylin Pharmaceuticals ...
Byetta Drug Facts & Information for Type 2 Diabetes
Information on dosage instructions, drug interactions, warnings and more associated with Byetta. Includes diabetes expert David Mendosa's personal experience with the diabetes ...
Eli Lilly and Company » Byetta® Media Kit
Welcome to the media kit for Byetta® (exenatide) injection. This online press kit is designed to bring you essential facts and background materials to help you tell the story ...
Byetta
Byetta is a prescription medicine that is approved to control blood sugar in people with type 2 diabetes. This eMedTV article describes how to administer the Byetta injections ...
Medication Guide
Page 1 of 8 Medication Guide BYETTA ® (bye-A-tuh) (exenatide) Injection Read this Medication Guide and the Pen User Manual that come with BYETTA before you start using it and each ...
Byetta Drug - Information on Byetta Drug
Research Byetta, news and resources on drug recalls such as Byetta. If you've experienced side effects while using the Byetta drug, you may have legal rights!
Amylin Pharmaceuticals » BYETTA® (exenatide) injection
BYETTA ® (EXENATIDE) INJECTION. BYETTA ® (exenatide) injection is a first-in-class type 2 diabetes therapy offering powerful, sustained A1C reductions with potential weight loss.
FDA Plans Sterner Warning for Diabetes Drug Byetta After 2 Deaths
The FDA said it plans to strengthen warnings about life-threatening pancreas problems linked to the type 2 diabetes drug Byetta after getting two reports of deaths and four other ...
Entry added by Creative Administrator
Creative Administrator also edited:
Here is what users have to say about Byetta

Exenatide (INN, marketed as Byetta) is one of a new class of medications (incretin mimetics) approved (Apr 2005) for the treatment of diabetes mellitus type 2. (It is not approved for use in diabetes mellitus type 1.) It is manufactured by Eli Lilly and Company.

Welcome to CWAnswers

CWAnswers is your guide to the sprawling world wide web. The directory aims to provide a useful guide made by users. You can share your knowledge as well - simply register and edit your first entry. For questions just contact the team at support - at - cwanswers.com.

Weblinks

Top 10

Things you find nowhere else.

Comments

You must be logged in to post a comment.

No comments yet on this topic. Be the first one!
These recent articles mention Byetta
Lilly Reports Solid Third-Quarter 2009 Results Revises Full-Year
MSN Money
Worldwide sales of Byetta were $205.7 million in the third quarter of 2009, a 2 percent increase compared with the third quarter of 2008, driven by growth in international markets. U.S. sales of Byetta declined 5 percent to $171.1 million c...
Takeda Jumps All Over Warning For Diabetes Drug Avandia
CNBC
... are working on a promising once-a-week shot for diabetes--a reconfigured version of the currently marketed twice-a-day injection called "Byetta". Many analysts believe the longer-acting form has multi-billion-dollar blockbuster potentia...
Backlash fear over 'diabetes disaster'
The Australian
In the meantime, Byetta remains available only on private prescription, at a cost of $200 a patient a month, and only a handful use it as a result. Jon Jureidini, a campaigner against pharmaceutical company influence on medical research and...
Diabetes Drug Byetta May Aid Weight Loss in Obese Patients
MedicineNet.com
Extra Calories From the Corner Store Weight-Loss Surgery Delay May Be Risky With Fancy Coffees, Calories Can Add Up Dieters With Success Show Unique Brain Patterns Diet, Exercise May Slow Kidney Disease Progression Want More News? Sign Up f...
Earnings Roundup: Sallie Mae, Cymer
ABC News
... earlier results were depressed by unfavorable currency comparisons. SAN DIEGO (AP) — Amylin Pharmaceuticals Inc. said its third-quarter loss narrowed as lower research and development costs offset a decline in sales of the diabetes trea...
Eli Lilly Posts 3Q Profit Ahead of Forecasts
ABC News
Revenue from collaborations with other companies and other revenue rose 51 percent to $176.5 million, mainly due to royalties from the cancer treatment Erbitux and sales of the diabetes treatment Byetta. Most of the restructuring costs in t...
Diabetes Drug Promotes Weight Loss
WebMD
Bray would also like to see studies to determine if combining Byetta or liraglutide with approved weight loss drugs leads to bigger weight loss than has been reported with any of the drugs alone. “It is clear that (Byetta and liraglutide) p...
Is Eli Lilly Ripe for a Rebound
MalaysiaNews.net
LLY )? Bears on the stock would point to a number of things. Lilly could lose an estimated 36% of its 2008 revenues of $20.3 billion from patents expiring on Zyprexa and Cymbalta by 2013. And, as...